CsrRS and environmental pH regulate group B Streptococcus adherence to human epithelial cells and extracellular matrix

Infection and Immunity

Volumn 80, Issue 11, 2012, Pages 3975-3984

  Park, Su Eun ^a,b   Jiang, Shengmei ^a   Wessels, Michael R ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b Pusan National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; FIBRINOGEN; FIBRONECTIN; POLYSTYRENE; SCLEROPROTEIN;

ARTICLE; BACTERIUM ADHERENCE; BIOFILM; ENVIRONMENTAL FACTOR; EPITHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; RESPIRATORY EPITHELIUM; STREPTOCOCCUS AGALACTIAE; TWO COMPONENT REGULATORY SYSTEM; VAGINA;

ADHESINS, BACTERIAL; BACTERIAL ADHESION; BACTERIAL PROTEINS; BIOFILMS; CELLS, CULTURED; EPITHELIAL CELLS; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; HYDROGEN-ION CONCENTRATION; PROTEIN KINASES; REAL-TIME POLYMERASE CHAIN REACTION; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 84867589360     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00699-12     Document Type: Article

References (51)

1. Al Safadi R, et al. 2011. Two-component system RgfA/C activates the fbsB gene encoding major fibrinogen-binding protein in highly virulent CC17 clone group B Streptococcus. PLoS One 6:e14658. doi:10.1371/ journal.pone.0014658.
2. Beckmann C, Waggoner JD, Harris TO, Tamura GS, Rubens CE. 2002. Identification of novel adhesins from Group B streptococci by use of phage display reveals that C5a peptidase mediates fibronectin binding. Infect. Immun. 70:2869-2876.
3. Botta GA. 1979. Hormonal and type-dependent adhesion of group B streptococci to human vaginal cells. Infect. Immun. 25:1084-1086.
4. Cheng Q, Stafslien D, Purushothaman SS, Cleary P. 2002. The group B streptococcal C5a peptidase is both a specific protease and an invasin. Infect. Immun. 70:2408-2413.
5. Donlan RM, Costerton JW. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15:167-193.
6. Dramsi S, et al. 2006. Assembly and role of pili in group B streptococci. Mol. Microbiol. 60:1401-1413.
7. Edwards MS, Baker CJ. 2001. Group B streptococcal infections, p 1091-1156. In Remington JS, Klein JO (ed), Infectious diseases of the fetus and newborn, 5th ed. W. B. Saunders, Philadelphia, PA.
8. Goldschmidt JCJ, Panos C. 1984. Teichoic acids of Streptococcus agalactiae: chemistry, cytotoxicity, and effect on bacterial adherence to human cells in tissue culture. Infect. Immun. 43:670-677.
9. Gutekunst H, Eikmanns BJ, Reinscheid DJ. 2003. Analysis of RogBcontrolled virulence mechanisms and gene repression in Streptococcus agalactiae. Infect. Immun. 71:5056-5064.
10. Gutekunst H, Eikmanns BJ, Reinscheid DJ. 2004. The novel fibrinogenbinding protein FbsB promotes Streptococcus agalactiae invasion into epithelial cells. Infect. Immun. 72:3495-3504.
11. Harris TO, Shelver DW, Bohnsack JF, Rubens CE. 2003. A novel streptococcal surface protease promotes virulence, resistance to opsonophagocytosis, and cleavage of human fibrinogen. J. Clin. Invest. 111:61-70.
12. Hauck CR, Ohlsen K. 2006. Sticky connections: extracellular matrix protein recognition and integrin-mediated cellular invasion by Staphylococcus aureus. Curr. Opin. Microbiol. 9:5-11.
13. Jiang S, Park SE, Yadav P, Paoletti LC, Wessels MR. 2012. Regulation and function of pilus island 1 in group B streptococcus. J. Bacteriol. 194: 2479-2490.
14. Jiang SM, Cieslewicz MJ, Kasper DL, Wessels MR. 2005. Regulation of virulence by a two-component system in group B Streptococcus. J. Bacteriol. 187:1105-1113.
15. Jiang SM, et al. 2008. Variation in the group B Streptococcus CsrRS regulon and effects on pathogenicity. J. Bacteriol. 190:1956-1965.
16. Johri AK, et al. 2007. Transcriptional and proteomic profiles of group B Streptococcus type V reveal potential adherence proteins associated with high-level invasion. Infect. Immun. 75:1473-1483.
17. Kaur H, Kumar P, Ray P, Kaur J, Chakraborti A. 2009. Biofilm formation in clinical isolates of group B streptococci from north India. Microb. Pathog. 46:321-327.
18. Konto-Ghiorghi Y, et al. 2009. Dual role for pilus in adherence to epithelial cells and biofilm formation in Streptococcus agalactiae. PLoS Pathog. 5:e1000422. doi:10.1371/journal.ppat.1000422.
19. Lamy MC, et al. 2004. CovS/CovR of group B streptococcus: a twocomponent global regulatory system involved in virulence. Mol. Microbiol. 54:1250-1268.
20. Lembo A, et al. 2010. Regulation of CovR expression in group B Streptococcus impacts blood-brain barrier penetration. Mol. Microbiol. 77: 431-443.
21. Lin WS, Cunneen T, Lee CY. 1994. Sequence analysis and molecular characterization of genes required for the biosynthesis of type 1 capsular polysaccharide in Staphylococcus aureus. J. Bacteriol. 176:7005-7016.
22. Maisey HC, Hensler M, Nizet V, Doran KS. 2007. Group B streptococcal pilus proteins contribute to adherence to and invasion of brain microvascular endothelial cells. J. Bacteriol. 189:1464-1467.
23. Mandlik A, Swierczynski A, Das A, Ton-That H. 2008. Pili in Grampositive bacteria: assembly, involvement in colonization and biofilm development. Trends Microbiol. 16:33-40.
24. Margarit I, et al. 2009. Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm. J. Infect. Dis. 199:108-115.
25. Mitchell TJ. 2003. The pathogenesis of streptococcal infections: from tooth decay to meningitis. Nat. Rev. Microbiol. 1:219-230.
26. Nealon TJ, Mattingly SJ. 1984. Role of cellular lipoteichoic acids in mediating adherence of serotype III strains of group B streptococci to human embryonic, fetal, and adult epithelial cells. Infect. Immun. 43:523-530.
27. Nobbs AH, Lamont RJ, Jenkinson HF. 2009. Streptococcus adherence and colonization. Microbiol. Mol. Biol. Rev. 73:407-450.
28. Poyart C, Lamy MC, Boumaila C, Fiedler F, Trieu-Cuot P. 2001. Regulation of D-alanyl-lipoteichoic acid biosynthesis in Streptococcus agalactiae involves a novel two-component regulatory system. J. Bacteriol. 183:6324-6334.
29. Pritchard DG, Lin B, Willingham TR, Baker JR. 1994. Characterization of the group B streptococcal hyaluronate lyase. Arch. Biochem. Biophys. 315:431-437.
30. Rinaudo CD, et al. 2010. Specific involvement of pilus type 2a in biofilm formation in group B Streptococcus. PLoS One 5:e9216. doi:10.1371/ journal.pone.0009216.
31. Rosenau A, et al. 2007. Evaluation of the ability of Streptococcus agalactiae strains isolated from genital and neonatal specimens to bind to human fibrinogen and correlation with characteristics of the fbsA and fbsB genes. Infect. Immun. 75:1310-1317.
32. Samen U, Eikmanns BJ, Reinscheid DJ, Borges F. 2007. The surface protein Srr-1 of Streptococcus agalactiae binds human keratin 4 and promotes adherence to epithelial HEp-2 cells. Infect. Immun. 75:5405-5414.
33. Samen U, et al. 2011. Rga is a regulator of adherence and pilus formation in Streptococcus agalactiae. Microbiology 157(Pt 8):2319-2327.
34. Samen UM, Eikmanns BJ, Reinscheid DJ. 2006. The transcriptional regulator RovS controls the attachment of Streptococcus agalactiae to human epithelial cells and the expression of virulence genes. Infect. Immun. 74:5625-5635.
35. Santi I, et al. 2009. CsrRS regulates group B Streptococcus virulence gene expression in response to environmental pH: a new perspective on vaccine development. J. Bacteriol. 191:5387-5397.
36. Santi I, et al. 2007. BibA: a novel immunogenic bacterial adhesin contributing to group B Streptococcus survival in human blood. Mol. Microbiol. 63:754-767.
37. Schubert A, et al. 2004. The fibrinogen receptor FbsA promotes adherence of Streptococcus agalactiae to human epithelial cells. Infect. Immun. 72:6197-6205.
38. Schubert A, et al. 2002. A fibrinogen receptor from group B Streptococcus interacts with fibrinogen by repetitive units with novel ligand binding sites. Mol. Microbiol. 46:557-569.
39. Scott JR, Zahner D. 2006. Pili with strong attachments: Gram-positive bacteria do it differently. Mol. Microbiol. 62:320-330.
40. Seifert KN, McArthur WP, Bleiweis AS, Brady LJ. 2003. Characterization of group B streptococcal glyceraldehyde-3-phosphate dehydrogenase: surface localization, enzymatic activity, and protein-protein interactions. Can. J. Microbiol. 49:350-356.
41. Spellerberg B. 2000. Pathogenesis of neonatal Streptococcus agalactiae infections. Microbes Infect. 2:1733-1742.
42. Spellerberg B, Rozdzinski E, Martin S, Weber-Heynemann J, Lutticken R. 2002. rgf encodes a novel two-component signal transduction system of Streptococcus agalactiae. Infect. Immun. 70:2434-2440.
43. Spellerberg B, et al. 1999. Lmb, a protein with similarities to the LraI adhesin family, mediates attachment of Streptococcus agalactiae to human laminin. Infect. Immun. 67:871-878.
44. Stålhammar-Carlemalm M, Areschoug T, Larsson C, Lindahl G. 1999. The R28 protein of Streptococcus pyogenes is related to several group B streptococcal surface proteins, confers protective immunity and promotes binding to human epithelial cells. Mol. Microbiol. 33:208-219.
45. Stålhammer-Carlemalm M, Stenberg L, Lindahl G. 1993. Protein Rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections. J. Exp. Med. 177:1593-1603.
46. Tamura GS, Kuypers JM, Smith S, Raff H, Rubens CE. 1994. Adherence of group B streptococci to cultured epithelial cells: roles of environmental factors and bacterial surface components. Infect. Immun. 62:2450-2458.
47. Tamura GS, Nittayajarn A, Schoentag DL. 2002. A glutamine transport gene, glnQ, is required for fibronectin adherence and virulence of group B streptococci. Infect. Immun. 70:2877-2885.
48. Tenenbaum T, Bloier C, Adam R, Reinscheid DJ, Schroten H. 2005. Adherence to and invasion of human brain microvascular endothelial cells are promoted by fibrinogen-binding protein FbsA of Streptococcus agalactiae. Infect. Immun. 73:4404-4409.
49. Tettelin H, et al. 2002. Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae. Proc. Natl. Acad. Sci. U. S. A. 99:12391-12396.
50. van Sorge NM, et al. 2009. The group B streptococcal serine-rich repeat 1 glycoprotein mediates penetration of the blood-brain barrier. J. Infect. Dis. 199:1479-1487.
51. Zawaneh SM, Ayoub EM, Baer H, Cruz AC, Spellacy WN. 1979. Factors influencing adherence of group B streptococci to human vaginal epithelial cells. Infect. Immun. 26:441-447.